期刊文献+

雷诺昔酚对去势后大鼠松质骨中TNF-α表达及骨密度的影响

Influence of raloxifene on expression of TNF-α in cancellous bone and bone mineral density in ovariectomized rats
下载PDF
导出
摘要 目的选择性雌激素受体调节剂(SERM)—雷诺昔酚(RAL)对去卵巢大鼠骨密度及松质骨中TNF-α表达的影响.方法将8月龄未经产雌性二级SD大鼠30只,随机分为假手术(SHAM)组、去势(OVX)组、去势+雷诺昔酚(OVX+RAL)组.OVX+RAL组大鼠术后第2日开始给予雷诺昔酚灌胃.术后20wk处死各组大鼠,对各组大鼠不同部位骨密度(BMD)进行检测.利用免疫组织化学染色及用图像分析方法对各组大鼠松质骨切片TNF-α表达图像进行分析,观察RAL对OVX大鼠腰椎松质骨中TNF-α表达的影响.结果①DVX组与SHAM组相比较,TNF-α表达的灰度值降低(P<0.01);RAL组较OVX组灰度值升高(P<0.01),表明OVX大鼠松质骨中骨小梁周围及髓腔内TNF-α表达阳性细胞数多于SHAM组;而经RAL治疗后的去卵巢大鼠骨小梁周围及髓腔内TNF-α阳性表达减弱.②与SHAM组相比,OVX组股骨近端、股骨干、腰椎BMD降低(P<0.01);RAL治疗组各部位BMD高于OVX组(P<0.05),接近SHAM组水平(P>0.05).结论RAL可通过抑制破骨性因子TNF-α表达来抑制因雌激素缺乏引起的骨密度降低及骨形态结构退变. AIM: To discuss the influence of selective estrogen receptor modulator(SERM) raloxifene(RAL) on the expression of TNF-α in cancellous bone and bone mineral density (BMD) loss in ovariectomized rats. METHODS: Thirty 8-month nulliparous female SD rats were divided into 3 groups ( 10 rats per group ) : sham operation ( SHAM ) group, ovariectomized (OVX) group and therapeutic (OVX + RAL)group. Bilateral ovariectomies were done on OVX group and OVX + RAL group. Sham operation was performed on SHAM group. OVX + RAL group was treated with RAL 2 d after operation. Twenty weeks after operation, all rats were sacrificed. BMD of L3-L5 vertebrae, proximal femoral segment, femoral body were measured by dual energy X-ray absorptiometry(DEXA). SABC immunohistochemistry and image analysis were used to detect the expression of TNF-α in L2 vertebral bone of every group. RESULTS : ① The gray scale of TNF-α in cancellous bone in OVX group was lower than that in SHAM group (P〈0.01), and also lower than that in OVX + RAL group (P 〈0.01 ), indicating that the expression of TNF-α in cancellous bone in OVX group increased after ovariectomy, and became weak after RAL treatment. ② Twenty weeks after ovarieetomy, BMD of L3 -L5 vertebrae, proximal femoral segment, femoral body of ovariectomized rats decreased significantly and the trabecular bone became thinner and irregular as compared with SHAM group ( P 〈 0.01 ). After treatment of RAL, the above parameters were maintained close to the level of SHAM group (P 〉 0. 05 ). CONCLUSION: RAL could inhibit the expression of TNF-α in cancellous bone of ovariectomized rats and depress the occurrence of osteoporosis in ovariectomized rats.
出处 《第四军医大学学报》 北大核心 2007年第10期881-884,共4页 Journal of the Fourth Military Medical University
关键词 骨质疏松 卵巢切除术 选择性雌激素受体调节剂 雷洛昔芬 骨密度 免疫组织化学 肿瘤坏死因子-α osteoporosis ovariectomy selective estrogen receptor modulator raloxifene bone density immunohistochemistry tumor necrosis factor-alpha
  • 相关文献

参考文献10

二级参考文献54

  • 1曹泽毅.中华妇产科学(第1版)[M].北京:人民卫生出版社,1999.35-37.
  • 21,Marsden J.Hormone replacement therapy and breast cancer.Maturitas,2000;34(Suppl 2):11
  • 3[1]Cummings SR,Eckert S,Kruegar K,et al.The effect of raloxifene on risk of breast cancer in postmenaupausal women: The eff ect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial.Multiple outcomes of raloxifene evaluation[J].J AMA,1999,281(23):2189-2197.
  • 4[2]Jordan VC,Glusman JE,Eckert S,et al.Inci dent primary breast cancers are reduced by raloxifene: integrated data from mult iceter double blind,randomized trial.In 12000 postmenopausal women[J].Pro c ASCO,1998,122a:466.
  • 5[3]Kauffman RF,Bensh WR,Roudebush RE,et al.Hypocholesterolemic activity of raloxifene(LY 139481): pharmacological character ization as a selective estrogen receptor modulator[J].J Pharmacol Exp Ther,1997,280(1):792-796.
  • 6[4]Yang NN,Bryant HU,Hardikar S,et al.Estro gen and raloxifene stimulate transforming growth-β3 gene expression in rat bon e: a potential mechanism for estrogen-or raloxifene-mediated bone maintainence [J].Endocrinology,1996,137(5):2075-2084.
  • 7[5]Lundeen SG,Carver JM,Mckaen MJ,et al.Cha racterization of the ovariectomized rat model for the evaluation of estrogen eff ect on plasma cholesterol levels[J].Endocrinology,1997,138(4):1552-1558 .
  • 8[6]Zuckerman SH,Bryan N.Inhibition of LDL oxi dation and myeloperoxidase dependent tyrosyl radical formatin by the selective e strogen receptor modulator raloxifene (LY 139481 HCl)[J].Atherosclerosis,1996,126(1):65-75.
  • 9[7]Bjarnason NH,Haarbo J,Byrjalsen I,et al.Raloxifene inhibits aortic accumulation of cheolesterol in ovariectomized,cheol esterol-fred rabbits[J].Circulation,1997,96(6):1964-1969.
  • 10[8]Clarkson TB,Anthony MS,Jerome CP.Lack of effect of raloxifene on coronary artery atherosclerosis of postmenauposal monkey s[J].J Clin Endocrinol Metab,1998,83(3):721-726.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部